Neil A Smith, DO
Psychiatry · Salinas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · County of Monterey · Solomon Medical Inc
Looking this up.
Hospitals listed: Community Hospital of the Monterey Peninsula. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Smith’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$18,144
Medicare paid this office $18,144 for 23 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 23 | $18,144 | $112 |
Who their Medicare patients are
23 Original Medicare patients in 2024. Average age 72 · Also on Medicaid 100% · Health risk score 2.59. Sicker patients than 9 in 10 peers; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 75% · COPD 52% · Diabetes 48%.
The office billed $191,763, Medicare allowed $23,832 and paid $18,144; for 162 services of 1 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 23 | 162 | 72 | 2.59 | $191,763 | $18,144 |
| 2023 | 24 | 148 | 72 | 2.22 | $124,976 | $16,854 |
| 2022 | 21 | 153 | 71 | 2.00 | $136,199 | $18,508 |
| 2021 | 18 | 103 | 71 | 2.09 | $94,430 | $12,236 |
| 2020 | 18 | 117 | 72 | 2.71 | $87,884 | $10,958 |
| 2019 | 17 | 88 | 72 | 2.17 | $50,144 | $7,831 |
| 2018 | 19 | 54 | 73 | 2.52 | $31,440 | $4,614 |
| 2017 | 17 | 45 | 72 | 2.90 | $25,238 | $3,870 |
| 2016 | 12 | 21 | 60 | 2.10 | $7,514 | $1,677 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Long return visit (40+ min) | 24 | $16,722 | $115 |
2022: 1 service
| Long return visit (40+ min) | 21 | $18,508 | $121 |
2021: 1 service
| Long return visit (40+ min) | 18 | $12,236 | $119 |
2020: 1 service
| Long return visit (40+ min) | 18 | $10,958 | $94 |
2019: 1 service
| Long return visit (40+ min) | 17 | $7,702 | $90 |
2018: 1 service
| Long return visit (40+ min) | 19 | $4,553 | $86 |
2017: 1 service
| Long return visit (40+ min) | 17 | $3,809 | $87 |
Drugs they prescribed that Part D paid
$124,580
Pharmacies billed $124,580 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,309) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
1,251 generic and 58 brand-name prescriptions · $124,580 in drug cost · 675 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Invega Sustenna | 30 | $85,664 | $2,855 |
| Vraylar | 12 | $15,963 | $1,330 |
| Lurasidone | 12 | $5,348 | $446 |
| Clozapine | 131 | $3,963 | $30 |
| Clozapine Odt | 19 | $2,939 | $155 |
See all 29 drugs
| Invega Sustenna | 30 | $85,664 | $2,855 |
| Vraylar | 12 | $15,963 | $1,330 |
| Lurasidone | 12 | $5,348 | $446 |
| Clozapine | 131 | $3,963 | $30 |
| Clozapine Odt | 19 | $2,939 | $155 |
| Aripiprazole | 138 | $2,046 | $15 |
| Quetiapine | 175 | $1,424 | $8 |
| Olanzapine | 84 | $1,068 | $13 |
| Divalproex Sodium Er | 84 | $1,059 | $13 |
| Haloperidol | 37 | $548 | $15 |
| Divalproex | 38 | $526 | $14 |
| Olanzapine Odt | 17 | $520 | $31 |
| Duloxetine | 36 | $475 | $13 |
| Risperidone | 72 | $343 | $5 |
| Perphenazine | 12 | $336 | $28 |
| Trazodone | 58 | $302 | $5 |
| Lorazepam | 69 | $216 | $3 |
| Quetiapine Fumarate Er | 12 | $190 | $16 |
| Venlafaxine Hcl Er | 22 | $171 | $8 |
| Clonazepam | 44 | $170 | $4 |
| Buspirone | 15 | $154 | $10 |
| Fluoxetine | 46 | $154 | $3 |
| Haloperidol Decanoate | 13 | $140 | $11 |
| Benztropine Mesylate | 15 | $110 | $7 |
| Lithium Carbonate | 22 | $104 | $5 |
| Sertraline | 24 | $99 | $4 |
| Escitalopram | 15 | $68 | $5 |
| Lamotrigine | 21 | $68 | $3 |
| Gabapentin | 13 | $48 | $4 |
Year by year
| 2024 | 1,309 | 32 | 0% (0) | 4% | $124,580 |
| 2023 | 1,469 | 34 | 0% (0) | 5% | $140,312 |
| 2022 | 1,224 | 32 | 0% (0) | 7% | $169,820 |
| 2021 | 838 | 22 | 0% (0) | 9% | $133,343 |
| 2020 | 977 | 23 | 0% (0) | 11% | $211,864 |
| 2019 | 1,121 | 36 | 0% (0) | 12% | $241,392 |
| 2018 | 1,003 | 45 | 0% (0) | 12% | $206,402 |
| 2017 | 742 | 20 | 0% (0) | 16% | $141,547 |
| 2016 | 75 | 18 | 0% (0) | None | $3,691 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Invega Sustenna | 17 | $45,108 | $2,653 |
| Vraylar | 18 | $26,191 | $1,455 |
| Aripiprazole | 116 | $19,141 | $165 |
| Quetiapine | 229 | $5,697 | $25 |
| Olanzapine | 91 | $4,995 | $55 |
| Divalproex Sodium Er | 98 | $4,739 | $48 |
| Clozapine | 135 | $4,630 | $34 |
| Olanzapine Odt | 27 | $2,905 | $108 |
| Divalproex | 44 | $1,511 | $34 |
| Risperidone | 74 | $1,500 | $20 |
| Duloxetine | 36 | $1,340 | $37 |
| Clonazepam | 56 | $1,291 | $23 |
| Lorazepam | 95 | $1,234 | $13 |
| Buspirone | 16 | $1,056 | $66 |
| Haloperidol | 30 | $985 | $33 |
| Perphenazine | 12 | $968 | $81 |
| Trazodone | 62 | $937 | $15 |
| Fluoxetine | 60 | $596 | $10 |
| Venlafaxine Hcl Er | 16 | $539 | $34 |
| Lithium Carbonate | 42 | $499 | $12 |
| Ziprasidone | 12 | $470 | $39 |
| Quetiapine Fumarate Er | 17 | $462 | $27 |
| Gabapentin | 12 | $445 | $37 |
| Escitalopram | 16 | $416 | $26 |
| Amitriptyline | 33 | $366 | $11 |
| Benztropine Mesylate | 20 | $319 | $16 |
| Sertraline | 24 | $177 | $7 |
| Lamotrigine | 15 | $173 | $12 |
2022: 26 drugs
| Invega Sustenna | 27 | $74,215 | $2,749 |
| Vraylar | 20 | $25,604 | $1,280 |
| Latuda | 14 | $21,167 | $1,512 |
| Aripiprazole | 60 | $9,104 | $152 |
| Clozapine | 132 | $8,168 | $62 |
| Olanzapine | 127 | $5,284 | $42 |
| Quetiapine | 176 | $5,019 | $29 |
| Olanzapine Odt | 19 | $3,571 | $188 |
| Quetiapine Fumarate Er | 31 | $3,123 | $101 |
| Divalproex Sodium Er | 64 | $3,072 | $48 |
| Duloxetine | 36 | $3,049 | $85 |
| Divalproex | 35 | $895 | $26 |
| Atropine Sulfate | 17 | $736 | $43 |
| Lorazepam | 86 | $630 | $7 |
| Clonazepam | 56 | $582 | $10 |
| Haloperidol | 24 | $564 | $23 |
| Buspirone | 23 | $554 | $24 |
| Risperidone | 30 | $466 | $16 |
| Lithium Carbonate | 42 | $362 | $9 |
| Trazodone | 42 | $255 | $6 |
| Fluoxetine | 50 | $255 | $5 |
| Sertraline | 20 | $160 | $8 |
| Benztropine Mesylate | 12 | $97 | $8 |
| Escitalopram | 15 | $76 | $5 |
| Venlafaxine Hcl Er | 12 | $75 | $6 |
| Gabapentin | 13 | $50 | $4 |
2021: 24 drugs
| Invega Sustenna | 34 | $72,427 | $2,130 |
| Latuda | 13 | $18,106 | $1,393 |
| Invega | 13 | $13,541 | $1,042 |
| Clozapine | 87 | $5,560 | $64 |
| Divalproex Sodium Er | 40 | $1,979 | $49 |
| Aripiprazole | 15 | $1,957 | $130 |
| Quetiapine | 124 | $1,799 | $15 |
| Quetiapine Fumarate Er | 16 | $1,664 | $104 |
| Duloxetine | 37 | $1,376 | $37 |
| Olanzapine | 80 | $1,161 | $15 |
| Risperidone | 36 | $580 | $16 |
| Hydroxyzine | 15 | $415 | $28 |
| Clonazepam | 50 | $312 | $6 |
| Lorazepam | 34 | $291 | $9 |
| Venlafaxine Hcl Er | 21 | $270 | $13 |
| Buspirone | 12 | $256 | $21 |
| Lithium Carbonate | 24 | $180 | $7 |
| Fluoxetine | 32 | $177 | $6 |
| Lamotrigine | 23 | $134 | $6 |
| Tamsulosin | 11 | $112 | $10 |
| Sertraline | 12 | $97 | $8 |
| Benztropine Mesylate | 12 | $97 | $8 |
| Escitalopram | 16 | $93 | $6 |
| Trazodone | 20 | $90 | $4 |
2020: 28 drugs
| Invega Sustenna | 40 | $92,037 | $2,301 |
| Fanapt | 31 | $42,237 | $1,362 |
| Invega | 14 | $28,824 | $2,059 |
| Latuda | 11 | $21,469 | $1,952 |
| Clozapine | 98 | $2,666 | $27 |
| Divalproex Sodium Er | 41 | $1,429 | $35 |
| Risperidone Odt | 13 | $1,407 | $108 |
| Olanzapine | 96 | $1,138 | $12 |
| Quetiapine | 97 | $966 | $10 |
| Quetiapine Fumarate Er | 13 | $736 | $57 |
| Risperidone | 53 | $721 | $14 |
| Olanzapine Odt | 20 | $667 | $33 |
| Duloxetine | 30 | $606 | $20 |
| Hydroxyzine | 15 | $478 | $32 |
| Aripiprazole | 13 | $470 | $36 |
| Clonazepam | 49 | $408 | $8 |
| Venlafaxine Hcl Er | 18 | $372 | $21 |
| Bupropion Xl | 22 | $350 | $16 |
| Benztropine Mesylate | 33 | $298 | $9 |
| Trazodone | 25 | $277 | $11 |
| Fluoxetine | 54 | $250 | $5 |
| Lorazepam | 43 | $189 | $4 |
| Sertraline | 13 | $147 | $11 |
| Buspirone | 13 | $130 | $10 |
| Lamotrigine | 18 | $115 | $6 |
| Hydroxyzine Pamoate | 15 | $110 | $7 |
| Lithium Carbonate | 26 | $89 | $3 |
| Escitalopram | 15 | $63 | $4 |
2019: 28 drugs
| Invega Sustenna | 44 | $98,593 | $2,241 |
| Fanapt | 41 | $52,847 | $1,289 |
| Invega | 12 | $28,780 | $2,398 |
| Latuda | 13 | $23,581 | $1,814 |
| Clozapine | 111 | $4,522 | $41 |
| Olanzapine | 147 | $3,071 | $21 |
| Fluphenazine Decanoate | 13 | $1,559 | $120 |
| Divalproex Sodium Er | 35 | $1,226 | $35 |
| Risperidone | 67 | $1,103 | $16 |
| Duloxetine | 23 | $917 | $40 |
| Olanzapine Odt | 22 | $904 | $41 |
| Risperidone Odt | 12 | $828 | $69 |
| Quetiapine | 87 | $815 | $9 |
| Clonazepam | 69 | $728 | $11 |
| Hydroxyzine | 18 | $518 | $29 |
| Bupropion Xl | 20 | $413 | $21 |
| Fluoxetine | 72 | $360 | $5 |
| Benztropine Mesylate | 36 | $331 | $9 |
| Trazodone | 44 | $294 | $7 |
| Lorazepam | 39 | $209 | $5 |
| Venlafaxine Hcl Er | 17 | $176 | $10 |
| Sertraline | 21 | $157 | $7 |
| Lamotrigine | 15 | $131 | $9 |
| Buspirone | 11 | $113 | $10 |
| Lithium Carbonate | 24 | $99 | $4 |
| Trihexyphenidyl | 13 | $93 | $7 |
| Escitalopram | 13 | $67 | $5 |
| Citalopram Hbr | 12 | $47 | $4 |
2018: 26 drugs
| Invega Sustenna | 36 | $71,210 | $1,978 |
| Fanapt | 41 | $49,447 | $1,206 |
| Latuda | 19 | $30,710 | $1,616 |
| Invega | 12 | $27,084 | $2,257 |
| Olanzapine | 122 | $2,842 | $23 |
| Clozapine | 55 | $2,662 | $48 |
| Divalproex Sodium Er | 25 | $1,886 | $75 |
| Fluphenazine Decanoate | 14 | $1,573 | $112 |
| Risperidone Odt | 14 | $1,527 | $109 |
| Clonazepam | 52 | $1,214 | $23 |
| Risperidone | 58 | $845 | $15 |
| Quetiapine | 58 | $786 | $14 |
| Olanzapine Odt | 17 | $670 | $39 |
| Haloperidol | 17 | $592 | $35 |
| Fluoxetine | 79 | $472 | $6 |
| Bupropion Xl | 15 | $465 | $31 |
| Duloxetine | 17 | $370 | $22 |
| Lorazepam | 54 | $370 | $7 |
| Benztropine Mesylate | 25 | $301 | $12 |
| Divalproex | 20 | $253 | $13 |
| Sertraline | 38 | $191 | $5 |
| Venlafaxine Hcl Er | 18 | $174 | $10 |
| Trazodone | 36 | $150 | $4 |
| Lithium Carbonate | 31 | $144 | $5 |
| Lamotrigine | 12 | $115 | $10 |
| Trihexyphenidyl | 14 | $73 | $5 |
2017: 21 drugs
| Latuda | 44 | $59,410 | $1,350 |
| Fanapt | 29 | $28,792 | $993 |
| Nuedexta | 12 | $9,374 | $781 |
| Risperidone Odt | 23 | $5,492 | $239 |
| Divalproex Sodium Er | 41 | $3,289 | $80 |
| Clonazepam | 46 | $2,037 | $44 |
| Olanzapine | 78 | $1,133 | $15 |
| Quetiapine | 74 | $949 | $13 |
| Aripiprazole | 13 | $536 | $41 |
| Risperidone | 40 | $475 | $12 |
| Bupropion Xl | 12 | $340 | $28 |
| Fluoxetine | 49 | $322 | $7 |
| Venlafaxine Hcl Er | 19 | $261 | $14 |
| Divalproex | 22 | $169 | $8 |
| Lamotrigine | 18 | $117 | $6 |
| Trazodone | 30 | $114 | $4 |
| Lithium Carbonate | 23 | $105 | $5 |
| Citalopram Hbr | 12 | $76 | $6 |
| Lorazepam | 12 | $63 | $5 |
| Sertraline | 17 | $56 | $3 |
| Trihexyphenidyl | 12 | $29 | $2 |
Professional record
- NPI
- 1578628053
- Licence
- CA 2OA9199
- Group
- County of Monterey · Solomon Medical Inc
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 7797 N 1st St # 14, Fresno, CA, 93720
- NPI first listed
- 2006-12-26
- NPI last updated
- 2012-02-11
This is when the NPI record was last certified, not a medical board exam.